CryOSA has filed a notice of an exempt offering of securities to raise $15 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, CryOSA is raising up to $15,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About CryOSA
Cryosa is a clinical stage company developing a treatment for moderate to severe Obstructive Sleep Apnea (OSA). We believe that mask-free, hose-free, implant-free treatment is possible. Everyone is free to sleep, free to rest and free to live brighter days. OSA Is a Big Problem. MILLIONS OF PEOPLE are affected by OSA worldwide and the current treatment options are suboptimal. Many people cannot tolerate positive airway pressure therapies and alternatives require painful surgeries or implants. But We Want To Change That. Experience + Success. Cryosa is led by an experienced team with deep roots in the medical device industry. Our team is made up of successful startup entrepreneurs, engineers, and seasoned medical device executives. Together, were paving a new way to treat obstructive sleep apnea.
To learn more about CryOSA, visit https://cryosa.com/
CryOSA Linkedin Page: https://www.linkedin.com/company/cryosa/
Contact:
Laura Stoltenberg, Chief Executive Officer
210-748-7121
https://www.linkedin.com/in/laura-stoltenberg-bb1a412/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.